Request Trial
istock-835833976_sergey-tinyakov
Sergey Tinyakov / iStockphoto.com
12 October 2018BiotechnologyLaurence Gainey

How the EPO treats personalised healthcare patents

Personalised healthcare, or precision medicine, is an evolving field where a therapeutic treatment is tailored to an individual with a particular disease. The aim is to target the right treatment to the right patient, typically by using a diagnostic test (companion diagnostic test) for one or more biomarkers indicative of drug response.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
‘Doing more with less’: In-house counsel on budgets and strategy
22 October 2025   Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.
Biotechnology
An update on patenting in Ukraine, Russia and Eurasia
2 September 2025   Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region.
Biotechnology
Synthego clears rival’s patents from CRISPR market at Fed Circ
12 June 2025   Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to be anticipated by prior art.


Editor's picks

Final call: Who are the world’s best in-house counsel?
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026

Editor's picks

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

Chinese biotech strikes billion dollar deal in nextgen cancer race
Italian medtech startup beats larger US rival in UPC dispute
Goodwin targets transatlantic patent work with London hire
Bayer secures key Denmark ruling as Xarelto faces expiry pressure
Carpmaels & Ransford builds Munich UPC team with elite hire
Why the US is poised for a patent litigation surge in 2026
How AI will be shaped by legal and regulatory developments in 2026
Arnold & Porter loses another regulatory partner to growing rival